I graduated from Ehime University, Japan, obtaining a Doctor of Medicine degree and a medical license in 2004. I had been training and working as a general surgeon, breast surgeon, and oncologist in clinical hospital, cancer center, and Hiroshima University Hospital. I received my PhD degree for research on Wnt5a signaling pathway in breast cancer from Hiroshima University, Japan, in 2018.
My long-term research goal is to elucidate the mechanism of late recurrence in especially ER-positive breast cancer and establish personalized therapy for recurrent breast cancer. Since I became a medical doctor, I had seen huge breast cancer patients with various disease conditions in clinic. I had frequently seen the patients with recurrence, most of which eventually die because of the disease. I had been feeling terribly sad and really eager to develop novel therapeutic strategy to overcome recurrent breast cancer.
When I was a PhD student, I thought that particular signaling pathways may link to the drug sensitivity and prognosis of breast cancer, and if we identify such pathways, they may serve as drug targets as well as predictive biomarkers. I hope that I would like to make contributions to clinical applications and become a bridge between basic researchers and clinicians.
I currently work for Department of Breast Oncology, National Hospital Organization
Kure Medical Center and Chugoku Cancer Center since April 2022 as a breast surgeon and oncologist.
I graduated from Ehime University, Japan, obtaining a Doctor of Medicine degree and a medical license in 2004. I had been training and working as a general surgeon, breast surgeon, and oncologist in clinical hospital, cancer center, and Hiroshima University Hospital. I received my PhD degree for research on Wnt5a signaling pathway in breast cancer from Hiroshima University, Japan, in 2018.
My long-term research goal is to elucidate the mechanism of late recurrence in especially ER-positive breast cancer and establish personalized therapy for recurrent breast cancer. Since I became a medical doctor, I had seen huge breast cancer patients with various disease conditions in clinic. I had frequently seen the patients with recurrence, most of which eventually die because of the disease. I had been feeling terribly sad and really eager to develop novel therapeutic strategy to overcome recurrent breast cancer.
When I was a PhD student, I thought that particular signaling pathways may link to the drug sensitivity and prognosis of breast cancer, and if we identify such pathways, they may serve as drug targets as well as predictive biomarkers. I hope that I would like to make contributions to clinical applications and become a bridge between basic researchers and clinicians.
I currently work for Department of Breast Oncology, National Hospital Organization
Kure Medical Center and Chugoku Cancer Center since April 2022 as a breast surgeon and oncologist.